The role of OPG in the pathological aspects of bone diseases, such as osteoporosis associated with estrogen deficiency and periodontal disease, has been well established (Bostanci et al., 2007; Koide et al., 2013; Hofbauer et al., 1999). Here, TNFRSF11B is linked to osteoporosis.